CVR: 36687193
DKK -15,933
Gross profit
Net result: DKK 36,023
Hans-Ole Hedegaard
CVR · view ownership and management
Director registered: Mads Juul Hedegaard
CVR · 31/08/2026
View the full event history
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.
Virksomhedens formål er at udvikle og formidle lægemidler til videresalg.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | -16 t. | 36 t. | 973 t. | -275 t. | 0 | |
| 202401/10/2023 – 30/09/2024 | -14 t. | -19 t. | 933 t. | -311 t. | 0 | |
| 202301/10/2022 – 30/09/2023 | -10 t. | 15 t. | 952 t. | -292 t. | 0 | |
| 202201/10/2021 – 30/09/2022 | 8 t. | -242 t. | 966 t. | -307 t. | - | |
| 202101/10/2020 – 30/09/2021 | 337 t. | 383 t. | 1.2 mio. | -65 t. | - | |
| 202001/10/2019 – 30/09/2020 | 373 t. | 76 t. | 884 t. | -448 t. | - | |
| 201901/10/2018 – 30/09/2019 | 382 t. | -907 t. | 615 t. | -524 t. | - | |
| 201801/10/2017 – 30/09/2018 | 345 t. | -237 t. | 1.5 mio. | 383 t. | - | |
| 201701/10/2016 – 30/09/2017 | 357 t. | 270 t. | 1.7 mio. | 619 t. | - | |
| 201601/10/2015 – 30/09/2016 | 397 t. | 296 t. | 1.3 mio. | 349 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationPharmagen ApS was founded on 18 March 2015.
Pharmagen ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Pharmagen ApS is owned by Hans-Ole Hedegaard.
In 2025, Pharmagen ApS reported a gross profit of DKK -15,933.
The management of Pharmagen ApS consists of Mads Juul Hedegaard.
Pharmagen ApS is located at Grusbakken 2D, 2820 Gentofte.
Claim this page to add your logo and social links. Free to get started.
As of August 31, 2026, Mads Juul Hedegaard is registered as director of Pharmagen ApS.
As of July 27, 2026, Hans-Ole Hedegaard has stepped down as director of Pharmagen ApS.
Pharmagen ApS has published its annual report for 2025. Gross profit came to DKK -15,933, and the net result was DKK 36,023.
Pharmagen ApS has published its annual report for 2024. Gross profit came to DKK -14,201, and the net result was DKK -19,304.
Pharmagen ApS has published its annual report for 2023. Gross profit came to DKK -10,057, and the net result was DKK 15,308.
Pharmagen ApS has published its annual report for 2022. Gross profit came to DKK 7,857, and the net result was DKK -242,071.
Pharmagen ApS has published its annual report for 2021. Gross profit came to DKK 337,172, and the net result was DKK 383,322.
Pharmagen ApS has published its annual report for 2020. Gross profit came to DKK 373,318, and the net result was DKK 75,955.
Pharmagen ApS has published its annual report for 2019. Gross profit came to DKK 382,076, and the net result was DKK -906,880.
As of December 17, 2019, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Pharmagen ApS.
As of May 1, 2019, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Pharmagen ApS.
As of May 1, 2019, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Pharmagen ApS.
Pharmagen ApS has published its annual report for 2018. Gross profit came to DKK 344,900, and the net result was DKK -236,511.
Pharmagen ApS has published its annual report for 2017. Gross profit came to DKK 356,650, and the net result was DKK 269,922.
Pharmagen ApS has published its annual report for 2016. Gross profit came to DKK 396,649, and the net result was DKK 295,924.
As of September 13, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Pharmagen ApS.
Pharmagen ApS has published its interim report for the period March 18, 2015 – September 30, 2015.
As of March 18, 2015, Hans-Ole Hedegaard is registered as director of Pharmagen ApS.
As of March 18, 2015, Hans-Ole Hedegaard is registered as an owner of Pharmagen ApS with an ownership share of 100%.
Pharmagen ApS was founded on March 18, 2015.
Companies in the same industry and area
CVR 43002570
CVR 32083560
CVR 42812056
CVR 14605185
CVR 40831622
